ID   SK-MEL-413-2
AC   CVCL_1T72
SY   SK-Mel-413-2
DR   cancercelllines; CVCL_1T72
DR   Wikidata; Q54954163
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
RX   PubMed=24576830; DOI=10.1158/0008-5472.CAN-13-2625; PMCID=PMC4005042;
RA   Nissan, Moriah Heller
RA   Pratilas, Christine A.
RA   Jones, Alexis M.
RA   Ramirez, Ricardo
RA   Won, Helen
RA   Liu, Cai-Lian
RA   Tiwari, Shakuntala
RA   Kong, Li
RA   Hanrahan, Aphrothiti J.
RA   Yao, Zhan
RA   Merghoub, Taha
RA   Ribas, Antoni
RA   Chapman, Paul B.
RA   Yaeger, Rona D.
RA   Taylor, Barry Stephen
RA   Schultz, Nikolaus
RA   Berger, Michael F.
RA   Rosen, Neal
RA   Solit, David B.
RT   "Loss of NF1 in cutaneous melanoma is associated with RAS activation
RT   and MEK dependence.";
RL   Cancer Res. 74:2340-2350(2014).
//